Digital Solutions for Medical Affairs Teams

Effectively reach patients, HCPs, sponsors, authorities, and more

Learn More
international marketing

Digital and technology-backed workflows to assist with content, localization, and management of medical affairs content

Historically, pharmaceutical companies have organized the medical affairs department regionally instead of globally by therapeutic area. While this structure may be closer to constituents, it can produce substantial regional differences in how organizations communicate medical information to patients and other stakeholders, potentially affecting the patient and stakeholder experience.

Evolve your medical affairs communications from a regional to global, integrated model with TransPerfect Life Sciences’ tptdigital solution for Med Affairs teams.

CONTACT US ›

360 Workflow Solutions To Meet Your Medical Affairs Initiatives

  • Content creation & adaption
  • SEO best practices
  • SEM global strategies
  • Social media management & strategy
  • Multilingual video creation
tpt dig

Enhancing Communications Globally for Key Stakeholders

Attract and keep your target audience’s attention with our specialized digital division’s support

Schedule a Free Consult ›

Improve customer engagement through innovative digital solutions and interactive content

Get in Touch ›

News and Press Releases

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations.

Xtalks | EU Clinical Trial Regulation: Latest Developments and Upcoming Opportunities

The EU clinical trial landscape has changed significantly since Regulation (EU) No 536/2014 became applicable on January 31, 2022, and sponsors now need a clear view of how the framework is operating in practice and where it may evolve next. This webinar explores the current status of clinical trial regulation in the EU, including experience with Clinical Trial Information System (CTIS), updated transparency expectations and emerging regulatory developments. Since ...

Xtalks | EU Clinical Trial Regulation: Latest Developments and Upcoming Opportunities
White Paper

The Current State of AI in Translation for Clinical Content

AI is reshaping how clinical trial content gets translated and localized, but in a regulated environment, speed can't come at the cost of accuracy or traceability. This white paper breaks down where AI delivers real value, where human oversight remains essential, and how to ...
Guide

The Veeva Vault RIM Translation Integration

Managing multilingual regulatory submissions shouldn't mean chasing files across email threads and re-entering metadata by hand. This playbook breaks down how direct translation integration with Veeva Vault RIM eliminates manual bottlenecks, preserves compliance, and cuts ...
Guide

Buyer's Guide: Translation Management Integration with Veeva Vault RIM

Translation bottlenecks, fragmented audit trails, and uncontrolled AI output aren't edge cases in regulatory operations; they're the predictable result of a poorly integrated workflow. This buyer's guide is built for regulatory leaders who need more than a file ...
Webinar

LifeSci Talks COA Series | Are We Sacrificing Good for Perfect in Clinical Outcome Assessment?

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacie Hudgens, Chief Scientific and Strategy Officer at Clinical Outcome Solutions, to discuss whether the field of clinical outcome assessment has started ...
Blog

AI Governance in Medical Information: What "Human-in-the-Loop" Actually Requires

These days, you can't have a conversation about AI in life sciences without someone invoking "human-in-the-loop." It's become so expected that leaving it out feels like a red flag—a signal that AI governance hasn't been fully considered. The problem isn't the phrase...
Event

C3 Summit 2025 - London

Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to ...

Ready to Enhance Your Relationship with Key Stakeholders?

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.